Iris Loew-Friedrich

Executive Vice President Chief Medical Officer
Biopharmaceutical
UCB
Spain

Professor Immunology
Biography

 Prof. Dr. med. Iris Loew-Friedrich is Executive Vice President and Chief Medical Officer, UCB. She provides strategic global leadership for project leadership, world-wide clinical development, medical affairs and global regulatory affairs for UCB’s portfolio of pipeline projects and products

Research Intrest

 Her mission is to lead UCB’s Development and Medical Practices and help develop patient solutions with proven superior and sustainable value for patients suffering from severe diseases. Dr. Loew-Friedrich also oversees UCB’s Patient Affairs function, which places a strategic focus on better understanding and improving the patient experience in currently underserved medical areas in immunological and neurological diseases.